Eaton Vance Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1.73M Buy
33,588
+138
+0.4% +$8.19K ﹤0.01% 1100
2022
Q2
$1.76M Sell
33,450
-2,529
-7% -$176K ﹤0.01% 1117
2022
Q1
$3.09M Buy
35,979
+30,056
+507% +$2.47M ﹤0.01% 1037
2021
Q4
$484K Buy
5,923
+122
+2% +$8.92K ﹤0.01% 1339
2021
Q3
$229K Buy
5,801
+2,328
+67% +$165K ﹤0.01% 1315
2021
Q2
$233K Buy
3,473
+1,878
+118% +$116K ﹤0.01% 1550
2021
Q1
$83K Buy
+1,595
New +$80.6K ﹤0.01% 1649
2016
Q4
Sell
-44,863
Closed -$1.02M 1014
2016
Q3
$1.02M Hold
44,863
﹤0.01% 703
2016
Q2
$1.24M Hold
44,863
﹤0.01% 653
2016
Q1
$1.3M Sell
44,863
-2,146
-5% -$55.8K ﹤0.01% 629
2015
Q4
$1.42M Buy
47,009
+14,193
+43% +$466K ﹤0.01% 620
2015
Q3
$1.21M Buy
+32,816
New +$1.7M ﹤0.01% 637

Other funds holding THC

Eaton Vance Management's THC Position: Q3 2022 in Review

Eaton Vance Management increased its Tenet Healthcare (THC) stake by 0.41% in Q3 2022, buying an estimated $8.19K and bringing the position to 33,588 shares worth $1.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1100.

Eaton Vance Management first reported a position in THC in Q3 2015 and has held it in 12 quarters since. The position peaked at $3.09M in Q1 2022. 362 funds tracked by Wall St. Rank hold THC as of Q3 2022.

  • Eaton Vance Management held 33,588 shares of Tenet Healthcare worth $1.73M as of Q3 2022.
  • Eaton Vance Management bought 138 Tenet Healthcare shares in Q3 2022, an estimated $8.19K.
  • Tenet Healthcare made up ﹤0.01% of Eaton Vance Management's portfolio in Q3 2022, its #1100 holding.
  • Eaton Vance Management first reported a position in Tenet Healthcare in Q3 2015 and has held it in 12 quarters since.
  • Eaton Vance Management's Tenet Healthcare position peaked at $3.09M in Q1 2022.
  • 362 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2022.

Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.